Page 11234..1020..»

Hello Doctor Nandani Gokulchandran On Stem Cell Therapy Treatment 20th July 2014 – Video

without comments




Hello Doctor Nandani Gokulchandran On Stem Cell Therapy Treatment 20th July 2014 By: zee chovis taas

Source Link(s) Are Here

Hello Doctor Nandani Gokulchandran On Stem Cell Therapy Treatment 20th July 2014 - Video

Written by admin

July 22nd, 2014 at 6:45 am

Celladon Corporation Announces In-License of Stem Cell Factor Development Program

without comments

SAN DIEGO — Celladon Corporation , a clinical-stage biotechnology company applying its leadership position in the field of gene therapy and calcium dysregulation today announced an exclusive, global license …



Source Link(s) Are Here

Celladon Corporation Announces In-License of Stem Cell Factor Development Program

Arthritis Alleviated: MetroMD Introduces Latest in Stem Cell Therapy in LA; Promises to be Especially Helpful for …

without comments

Los Angeles, CA (PRWEB) July 22, 2014 MetroMD, one of the leading names in regenerative medicines in all of California and one of the greatest proponents of holistic health services, now brings a reason to rejoice for individuals long suffering from debilitating arthritis. As per a report published on March 6 2013, by The Journal of Bone and Joint Surgery on The US National Library of Medicine National Institutes of Health (Ref: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748969/), on an average, around 500,000 revision of knee replacement surgeries were recorded in the US – with the prime reason being osteoarthritis in majority of these cases. And If Mr



Source Link(s) Are Here

Arthritis Alleviated: MetroMD Introduces Latest in Stem Cell Therapy in LA; Promises to be Especially Helpful for ...

Written by admin

July 22nd, 2014 at 6:45 am

ViaCyte asks FDA for go-ahead with human trials of cell replacement therapy for diabetes

without comments

ViaCyte, a privately held regenerative medicine company developing a cell replacement therapy for the treatment of diabetes, has filed an Investigational New Drug application with the United States Food and Drug Administration, seeking to start a Phase 1/2 clinical trial in patients with type 1 diabetes, it was reported on Friday. The trial will assess the safety and efficacy of ViaCyte’s VC-01 product candidate, a stem cell-derived, encapsulated cell replacement therapy. The company has also submitted a Medical Device Master File to the United States Food and Drug Administration in support of the Encaptra drug delivery system, the device component of the VC-01 product candidate.



Source Link(s) Are Here

ViaCyte asks FDA for go-ahead with human trials of cell replacement therapy for diabetes

Steven R. Gerst Talks About How Obamacare and How 2015 Deadline for Digital Medical Records is Making the Field of …

without comments

Health Informatics is an industry with tremendous growth area due to requirements and changes in the Affordable Care Act, as well as American Recovery and Reinvestment Act digital records requirements. Employers will need experts to fulfill job positions in this lucrative industry. (PRWeb July 22, 2014) Read the full story at http://www.prweb.com/releases/2014/07/prweb12023970.htm



Source Link(s) Are Here

Steven R. Gerst Talks About How Obamacare and How 2015 Deadline for Digital Medical Records is Making the Field of ...

PhytoScience Philippines Celeb Share good effect of Stem Cell Therapy – Video

without comments




PhytoScience Philippines Celeb Share good effect of Stem Cell Therapy TRENDING NOW! ANTI-AGING BREAKTHROUGH! ITS TIME TO SAY GOODBYE TO SKIN PROBLEM! -NO PAINFUL INJECTION -NO EXPENSIVE TREATMENT -NO INVASIVE SURGERY PHYTOSCIENCE DOUBLE STEM CELL removes the… By: Phytoscience Double Stem Cell PH

Source Link(s) Are Here

PhytoScience Philippines Celeb Share good effect of Stem Cell Therapy - Video

Written by admin

July 21st, 2014 at 4:47 am

ViaCyte files investigational new drug application and device master file with FDA for novel cell replacement therapy …

without comments

Published 18 July 2014 ViaCyte a privately held regenerative medicine company developing a cell replacement therapy for the treatment of diabetes, announced that it has filed an Investigational New Drug application (IND) with the United States Food and Drug Administration (FDA) seeking to initiate a Phase 1/2 clinical trial in patients with type 1 diabetes. The trial would evaluate the safety and efficacy of ViaCyte’s VC-01 product candidate, a stem cell-derived, encapsulated cell replacement therapy. In a related development, ViaCyte submitted a Medical Device Master File (called MAF) to the FDA in support of the Encaptra drug delivery system, the device component of the VC-01 product candidate.



Source Link(s) Are Here

ViaCyte files investigational new drug application and device master file with FDA for novel cell replacement therapy ...

Written by admin

July 21st, 2014 at 4:47 am

( NewsUSA

without comments

) – You may not be able to spell or even pronounce the word “acetaminophen,” but almost 50 million Americans use it each week to manage pain and fever.



Source Link(s) Are Here

( NewsUSA

Stem RX Bioscience Solution Pvt Ltd hold awareness program on stem cell therapy – Video

without comments




Stem RX Bioscience Solution Pvt Ltd hold awareness program on stem cell therapy By: nmtvindia

Source Link(s) Are Here

Stem RX Bioscience Solution Pvt Ltd hold awareness program on stem cell therapy - Video

Written by admin

July 20th, 2014 at 1:52 pm

Stem Cell Therapy in Cardiac Disease – Charles Murry, MD, Ph.D. – Video

without comments




Stem Cell Therapy in Cardiac Disease – Charles Murry, MD, Ph.D. How can we harness the power of stem cells to repair the heart or other damaged organs

Source Link(s) Are Here

Stem Cell Therapy in Cardiac Disease - Charles Murry, MD, Ph.D. - Video

Written by admin

July 20th, 2014 at 1:52 pm


Page 11234..1020..»